This year we’re giving thanks to all our frontline heroes both out in the field protecting our loved ones, and those in the lab tirelessly working on a vaccine for the global pandemic.

Papers is committed to helping researchers around the world fight COVID-19. Back in March, Papers partnered with publishers Springer Nature, Wiley, and JAMA to open over 26 million articles as part of the ReadCube COVID-19 Research Pass in an effort to help accelerate research discovery.

As part of the Research Pass program, those registered can access and share full-text articles with one click via the Share Link. Any person with the link can automatically gain access to all open access content. For any paywalled content, users will need to register for the program first.

Curious to see how the Research Pass link sharing works? Access a few articles below around different topics related to COVID-19. These papers were chosen based on their Altmetric scores and publish date.

Risk of Severe COVID-19 Among Workers and Their Household Members –

https://rdcu.be/cbfYx

This survey study uses prepandemic data to estimate how many adults at increased risk of severe COVID-19 held essential jobs and could not work at home or lived in households with such workers.

Why will it never be known if convalescent plasma is effective for COVID-19 –

https://rdcu.be/cbfYT

High expectations have been set around convalescent plasma (CP) for the treatment of COVID-19. However, none of the randomized controlled trials (RCTs) conducted so far have reached their primary endpoints. Therefore, at this time there is insufficient evidence to recommend for or against the use of CP as a treatment for COVID-19.

Incubation Period of Severe Acute Respiratory Syndrome Novel Coronavirus 2 that Causes Coronavirus Disease 2019: A Systematic Review and Meta-Analysis –

https://rdcu.be/cbfZ3

The pooled average incubation period of SARS-CoV-2 (COVID-19) was about 6 days, with the longest incubation period observed in China. Global health initiatives, as well as local health planners, should consider this average incubation period when designing optimal prevention and control strategies for COVID-19.

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results –

https://rdcu.be/cbf0z

This study suggests that vitamin D deficiency may play a role in the development of COVID-19.

COVID-19 herd immunity: where are we? –

https://rdcu.be/cbi6U

Herd immunity is likely not a viable strategy for mitigating cases of COVID-19 infection.

As always, if you have any questions, please contact us at [email protected]. We wish you and your families a Happy and Healthy Thanksgiving!